EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection

Rie Kubota, Takako Komiyama, Naoki Kumagai, Miyuki Kimijima, Keiko Mitsuki, Junko Uetake, Fumihiko Kaneko, Satoshi Tsunematsu, Kanji Tsuchimoto

Hepatitis Research and Treatment · 2010

DOI: 10.1155/2010/495928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von Rie Kubota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Practice and Sciences, Department of Clinical Pharmacy, Center for Clinical Pharmacy and Sciences, School of Pharmacy, Kitasato University, …. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims . To determine whether the erythrocyte phosphorylated ribavirin (RBV) level might be a useful index of EVR and risk of anemia and to determine the optimal dose of RBV in 24 patients with hepatitis C with pegylated interferon and RBV. Methodology . The RBV level was measured by a high-performance liquid chromatography. Results and Conclusion . In patients aged 50 years or over, a negative correlation (, ) was observed between the RBV level at week 2 and rate of Hb reduction () at week 4. The at week 4 was significantly greater in patients with RBV levels of ≥800 ( %) than in patients with RBV levels

Autor:innen und Institutionen

  • Pharmacy Practice and Sciences, Department of Clinical Pharmacy, Center for Clinical Pharmacy and Sciences, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.

Zitieren

APA

Kubota, R., Komiyama, T., Kumagai, N., Kimijima, M., Mitsuki, K., Uetake, J., Kaneko, F., Tsunematsu, S., & Tsuchimoto, K. (2010). Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/495928

Vancouver

Kubota R, Komiyama T, Kumagai N, Kimijima M, Mitsuki K, Uetake J, et al. Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/495928

BibTeX
@article{Kubota2010,
  author = {Kubota, Rie and Komiyama, Takako and Kumagai, Naoki and Kimijima, Miyuki and Mitsuki, Keiko and Uetake, Junko and Kaneko, Fumihiko and Tsunematsu, Satoshi and Tsuchimoto, Kanji},
  title = {Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection},
  journal = {Hepatitis Research and Treatment},
  year = {2010},
  doi = {10.1155/2010/495928}
}
Kostenlos starten →